Medicinal Uses of Bee Venom: From Rheumatism to Epilepsy

Bee venom – the same substance that causes a sharp sting when a honeybee attacks – has been used as a healing agent for thousands of years. From ancient Egyptian remedies to Greek physician Hippocrates applying bee stings to patients around 460 BC, humans have long recognised the medicinal potential locked inside this tiny insect’s defence mechanism. Today, modern science is catching up with tradition, investigating exactly how the complex cocktail of peptides, enzymes, and bioactive compounds in bee venom can treat conditions ranging from rheumatism and inflammation to epilepsy and heart disease.

What is bee venom therapy? 🔗

Bee venom therapy, also known as apitherapy, is a branch of alternative medicine that uses products from honeybees – especially venom – to prevent and treat illness. The practice involves either direct bee stings or the injection of extracted and purified venom into the body. Venom can also be collected using mild electrical stimulation of hives, a technique perfected in the 1960s that allows bees to release venom without losing their stingers or dying. The collected substance, called apitoxin, is then dried and used in various clinical preparations including injections, creams, and acupuncture-based protocols.

One specialised form of the practice is apipuncture, which combines bee venom delivery with traditional acupuncture. In this approach, venom is administered directly at specific acupuncture points based on traditional Chinese or Korean medicine frameworks. In many traditional settings, however, live bees are simply placed on the patient’s skin and induced to sting, delivering the venom in its freshest and most bioactive form.

Key bioactive compounds in bee venom 🔗

Bee venom is not a single substance – it is a complex mixture of peptides, enzymes, and biogenic amines that together produce its wide range of biological effects. Understanding these individual components is essential for appreciating how the venom works medicinally.

Melittin 🔗

Melittin is the most abundant component of bee venom, making up roughly 40-50% of its dry weight. It is a powerful anti-inflammatory peptide that works by suppressing key inflammatory pathways and reducing markers like TNF-α and interleukin-1β. Research has shown that in small, controlled doses, melittin can significantly reduce inflammation, making it comparable in effect to pharmaceutical steroids – but through a different mechanism. Melittin is also the compound primarily responsible for the pain of a bee sting, and it has been studied extensively for its anti-cancer potential due to its ability to trigger programmed cell death (apoptosis) in tumour cells.

Apamin 🔗

Apamin is a small neurotoxic peptide that makes up about 2-3% of dry bee venom. What makes apamin unique is that it is the smallest known neurotoxin capable of crossing the blood-brain barrier, allowing it to directly affect the central nervous system. Apamin works by selectively blocking a specific type of ion channel in neurons called small-conductance calcium-activated potassium (SK) channels. These channels regulate how frequently neurons fire after an action potential. By blocking them, apamin can modulate neural activity – a property that has made it a valuable research tool and a potential therapeutic agent for neurological disorders.

Phospholipase A2 (PLA2) 🔗

Phospholipase A2 is the most significant enzyme in bee venom and one of its most pharmacologically studied components. PLA2 is a lipolytic enzyme that breaks down phospholipids, releasing fatty acids and lysophospholipids. In the context of medicine, PLA2 from bee venom has demonstrated anti-platelet aggregation and anti-coagulation activities, making it a candidate for developing anti-clotting drugs. It also plays a role in modulating the immune system, particularly by stimulating regulatory T cells – a type of immune cell involved in keeping inflammatory responses in check.

Adolapin and MCD peptide 🔗

Adolapin is a peptide with both anti-inflammatory and pain-relieving (analgesic) properties. It works by inhibiting cyclooxygenase activity, which is the same mechanism targeted by common anti-inflammatory drugs like aspirin and ibuprofen. The mast cell degranulating (MCD) peptide triggers the release of histamine from mast cells, which – in controlled doses – can modulate immune and inflammatory responses.

Bee venom for rheumatism and joint disorders 🔗

The most historically documented use of bee venom is for treating rheumatic conditions. The idea that beekeepers rarely suffer from rheumatism or joint problems is a long-held folk observation that eventually attracted scientific interest. Bee venom therapy for rheumatic diseases has been practised for at least 2,500 years, and the first scientific report on its use for rheumatic conditions was published in 1888 by Austrian physician Philipp Terč.

The anti-rheumatic effect is primarily attributed to melittin and PLA2 working together. Melittin reduces inflammation by suppressing the production of pro-inflammatory cytokines, while PLA2 modulates the immune response at the cellular level. Studies have found that many forms of rheumatic disease respond to bee venom therapy, including rheumatoid arthritis, osteoarthritis, gout, bursitis, tendinitis, fibromyalgia, and even lupus. A 2022 pharmacological review confirmed that bee venom offers multiple therapeutic actions relevant to joint disease, including anti-inflammatory, pain-relieving, and immune-modulating effects.

In traditional practice, a live bee is held against the skin near the affected joint, and the sting delivers the venom directly to the area. This method is considered the most potent form of delivery because the venom retains all of its volatile and bioactive components.

Anti-inflammatory and pain-relieving properties 🔗

Beyond rheumatism specifically, bee venom has broad anti-inflammatory effects that apply to many conditions involving chronic inflammation or pain. Scientific studies have confirmed that bee venom possesses anti-inflammatory, antioxidant, antibacterial, antiviral, and antifungal properties. The anti-inflammatory action is multi-pronged – melittin suppresses inflammatory signalling pathways, adolapin inhibits cyclooxygenase enzymes, and PLA2 modulates the immune cascade.

For conditions involving edema (swelling from trapped fluid in tissues), the venom’s ability to reduce inflammatory mediators and improve local circulation makes it useful. Traditional practitioners have applied bee stings to areas of swelling for centuries, and modern research supports the idea that the venom’s bioactive components can effectively reduce tissue oedema when applied in controlled doses.

The pain-relieving properties of bee venom are also significant. Compounds like adolapin and melittin can block pain signalling pathways, offering relief for conditions such as chronic arthritis pain, fibromyalgia, and neuropathic pain. This analgesic effect, combined with the anti-inflammatory action, is what makes bee venom particularly effective for musculoskeletal conditions.

Cardiovascular benefits: PLA2 and blood pressure 🔗

One of the more intriguing areas of bee venom research involves its effects on the cardiovascular system. Phospholipase A2, the major enzyme in bee venom, has been shown to have a significant blood-pressure-lowering (hypotensive) effect. In animal studies, PLA2 from bee venom produced a marked drop in blood pressure, particularly in subjects with elevated baseline blood pressure. This effect is partly mediated by PLA2 stimulating the production of prostacyclin (PGI2), a compound that relaxes blood vessels.

The cardiovascular potential does not stop at blood pressure. Research published in Toxins found that bee venom PLA2 significantly slowed the progression of atherosclerosis in animal models by increasing regulatory T cells and reducing lipid accumulation in arterial walls. This is significant because atherosclerosis – the buildup of plaque in arteries – is a leading cause of heart attacks and strokes. The study showed that PLA2 suppressed the formation of foam cells (the fat-laden immune cells that drive plaque buildup) in a mechanism dependent on regulatory T cells.

Additionally, bee venom PLA2 has demonstrated anti-platelet aggregation and anti-coagulation properties, meaning it can help prevent the formation of dangerous blood clots. These findings collectively suggest that specific bee venom components could one day contribute to cardiovascular therapies, though much more clinical research in humans is needed.

Neurological applications: from Parkinson’s to epilepsy 🔗

Some of the most exciting current research on bee venom involves its potential for treating neurological disorders. Bee venom components are recognised as sources of neuroprotectors and neuromodulators, with studies examining their use for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis (ALS), and epilepsy.

Parkinson’s disease 🔗

In Parkinson’s disease, the progressive loss of dopamine-producing neurons leads to motor impairment. Bee venom has shown promise here because apamin’s ability to block SK channels in the brain can promote the release of dopamine from midbrain neurons. A 2022 systematic review found that bee venom therapy improved motor function and reduced oxidative stress markers in Parkinson’s patients. When combined with standard Parkinson’s medications, bee venom appeared to enhance their therapeutic effects. PLA2 from bee venom has also been shown to protect dopaminergic neurons by promoting the generation of regulatory T cells, which help control the neuroinflammation that drives disease progression.

Alzheimer’s disease 🔗

In Alzheimer’s research, bee venom has demonstrated the ability to protect brain cells from the toxic effects of amyloid-beta peptides – the protein fragments that accumulate in Alzheimer’s brains. Animal studies have shown that bee venom treatment protected neurons from cell death, activated cell-protective pathways, and improved memory function. PLA2 has been specifically identified as a compound that modulates immune-related diseases including Alzheimer’s, through its ability to generate regulatory T cells.

Epilepsy 🔗

Epilepsy, a neurological disorder characterised by recurrent seizures, is another condition where bee venom research is gaining traction. SK channels – the specific ion channels blocked by apamin – have been proposed as therapeutic targets for epilepsy treatment. By modulating these channels, apamin can influence the electrical firing patterns of neurons that go haywire during seizures.

A study published in Metabolic Brain Disease evaluated bee venom acupuncture therapy in a pilocarpine-induced epilepsy model and found that the venom helped restore disrupted electrolyte balances, modulated neurotransmitter levels, and reduced pro-inflammatory cytokines associated with seizure activity. The neuroprotective and anti-neuroinflammatory properties of bee venom – driven by compounds including melittin, apamin, and PLA2 – may help reduce both the frequency and severity of seizures.

Separate research on oxidative stress during status epilepticus showed that bee venom reduced oxidative damage in brain, liver, and reproductive tissues of epileptic animal models. The bioactive amines in bee venom, such as histamine, serotonin, and norepinephrine, also facilitate nerve transmission and may help repair nerve damage – a useful property in conditions where seizure activity causes cumulative neuronal injury.

Other emerging applications 🔗

Beyond the conditions discussed above, bee venom is being actively researched for several other medical applications. Its anti-cancer potential has drawn significant attention – melittin has been shown to inhibit the growth of cancer cells by triggering apoptosis and stimulating local immune responses. Bee venom also demonstrates antimicrobial properties, showing effectiveness against certain bacteria, viruses, and fungi. In dermatology, bee venom is used in skincare products for its anti-inflammatory, antibacterial, and skin-regenerating effects. Clinical interest also extends to autoimmune conditions like multiple sclerosis, lupus, and psoriasis, where the venom’s ability to modulate immune function may help control overactive immune responses.

How bee venom is administered 🔗

There are several ways bee venom can be delivered for therapeutic purposes. The most traditional method is live bee sting therapy, where a practitioner places a live honeybee on the patient’s skin at a specific point and allows it to sting. This delivers the venom in its most complete and freshest form, retaining all volatile compounds that may be lost during extraction. It is also the most affordable method and has been the standard approach in traditional apitherapy for centuries.

Modern methods include injection of purified venom using syringes, which allows for more precise dosing. Bee venom acupuncture combines injection with traditional acupuncture point selection. Topical preparations such as creams, serums, and ointments are available for skin conditions and localised pain. Each method has its advantages – live stings offer maximum potency, while injections and topical products provide better dose control and reduced risk of severe allergic reactions.

Safety considerations and risks 🔗

Bee venom therapy is not without risks. A meta-analysis of 145 therapeutic studies on bee venom found that 58 of them reported adverse effects, with the most common being local swelling, skin reactions, and systemic immune responses. About 1% of the population is severely (hyper-allergic) allergic to bee venom and can experience anaphylaxis – a potentially fatal whole-body allergic reaction that requires immediate treatment with epinephrine.

For this reason, anyone considering bee venom therapy should undergo allergy testing beforehand. Practitioners should always have an epinephrine injector available during treatment sessions. A test sting is recommended if the person has not been stung within the past two weeks. It is also important to note that repeated exposure to bee venom can sometimes sensitise a person over time, meaning someone who previously tolerated stings well can develop a severe allergic reaction later.

While the therapeutic potential of bee venom is supported by a growing body of preclinical research and traditional use, large-scale, high-quality clinical trials in humans are still limited. Many of the most promising findings come from animal models, and the transition to proven human therapies requires further rigorous testing. Patients should always consult a qualified healthcare professional before pursuing bee venom therapy.

What do you think? With modern science beginning to validate what traditional healers have practised for millennia, do you believe bee venom could become a mainstream medical treatment in the future? And given the risks of allergic reactions, how should we balance the potential benefits of natural therapies against their safety concerns?

References

1. https://bestbees.com/bee-venom/
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6720840/
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC11434713/
4. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1412245/full
5. https://www.healthline.com/nutrition/bee-venom
6. https://en.wikipedia.org/wiki/Apamin
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC7809086/
8. https://beeculture.com/bee-venom-therapy/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC9965945/
10. https://www.sciencedirect.com/science/article/abs/pii/0041010180900501
11. https://pmc.ncbi.nlm.nih.gov/articles/PMC7598180/
12. https://pmc.ncbi.nlm.nih.gov/articles/PMC4549745/
13. https://link.springer.com/article/10.1007/s11011-021-00766-9
14. https://www.sciencedirect.com/science/article/abs/pii/S0143417923000495